Monogram Orthopaedics Inc ( ($MGRM) ) has issued an announcement. On July 28, 2025, Monogram Technologies Inc. provided its stockholders with FAQs ...

Zimmer Biomet Holdings, Inc. sees growth potential with Monogram acquisition enhancing robotics and Paragon 28 integration.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Zimmer Biomet has signed a definitive agreement to acquire orthopaedic robotics company Monogram Technologies for an upfront cash payment of $4.04 per share, reflecting an equity value of around ...

The Monogram acquisition will contribute to revenue growth in 2027 by improving Zimmer Biomet's robotic knee adoption in the U.S.

Zimmer Biomet now expects 5.7-8.2% revenue growth in 2025 with the Paragon 28 acquisition expected to boost growth by around 2.7%, despite the fact the deal only closed in late April.

The move is expected to bolster Zimmer’s ROSA Robotics platform with Monogram's semi-autonomous and fully autonomous robotic technologies.